Nov 03, 2022 / 12:30PM GMT
Operator
Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2022 Financial Results Conference Call. As a reminder, this conference call is being recorded. And I'd like to now turn the conference over to your host, Olivia Manser, Director of Investor Relations. Please go ahead.
Olivia Manser;Director - Investor Relations,
Thanks, Breanna. Good morning or good afternoon, everyone, and thanks for joining us to take part in today's call on the financial results and operational highlights for the third quarter for Autolus. I'm Olivia Manser, Director of Investor Relations. And with me on today's call, as usual, are Dr. Christian Itin, our Chief Executive Officer; and Dr. Lucinda Crabtree, our Chief Financial Officer.
So before we begin, I'd just like to remind you as usual that during today's call, our discussion will contain forward-looking statements. Please make sure you are familiar with our disclaimer slide, which is on Slide 2. And then turning to Slide 3, you'll see the agenda for today, which is as follows.
Q3 2022 Autolus Therapeutics PLC Earnings Call Transcript
Nov 03, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers